Fulvestrant
Fulvestrant · FULVESTRANT 25000 g/25000g · Injection · Steroid S.p.A.
NDC 49803-0011-01 · 2 BAG in 1 CONTAINER / 25000 g in 1 BAG · BULK INGREDIENT · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (bulk ingredient) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $720.69 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fulvestrant (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Sandoz Inc | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Accord Healthcare Inc. | FULVESTRANT 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| AstraZeneca Pharmaceuticals LP | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Avyxa Pharma, LLC | FULVESTRANT 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | FULVESTRANT 250 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Meitheal Pharmaceuticals Inc | FULVESTRANT 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Steroid S.p.A. | FULVESTRANT 25000 g/25000g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fulvestrant — NDC 49803-0011-01," retrieved September 3, 2026, https://drugdashboards.com/drug/49803001101.
Free to cite with attribution — see how the data is put together.